Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2011 2
2013 2
2014 9
2015 4
2016 3
2017 2
2018 3
2019 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research.
Beaton DE, Dyer S, Boonen A, Verstappen SM, Escorpizo R, Lacaille DV, Bosworth A, Gignac MA, Leong A, Purcaru O, Leggett S, Hofstetter C, Peterson IF, Tang K, Fautrel B, Bombardier C, Tugwell PS. Beaton DE, et al. Among authors: purcaru o. J Rheumatol. 2016 Jan;43(1):214-22. doi: 10.3899/jrheum.141077. Epub 2015 Sep 1. J Rheumatol. 2016. PMID: 26329339 Review.
Plasma levels of glucose and insulin in patients with brain tumors.
Alexandru O, Ene L, Purcaru OS, Tache DE, Popescu A, Neamtu OM, Tataranu LG, Georgescu AM, Tudorica V, Zaharia C, Dricu A. Alexandru O, et al. Among authors: purcaru os. Curr Health Sci J. 2014 Jan;40(1):27-36. doi: 10.12865/CHSJ.40.01.05. Epub 2013 Dec 29. Curr Health Sci J. 2014. PMID: 24791202 Free PMC article.
Worker productivity outcome measures: OMERACT filter evidence and agenda for future research.
Tang K, Boonen A, Verstappen SM, Escorpizo R, Luime JJ, Lacaille D, Fautrel B, Bosworth A, Cifaldi M, Gignac MA, Hofstetter C, Leong A, Montie P, Petersson IF, Purcaru O, Bombardier C, Tugwell PS, Beaton DE. Tang K, et al. Among authors: purcaru o. J Rheumatol. 2014 Jan;41(1):165-76. doi: 10.3899/jrheum.130815. Epub 2013 Oct 15. J Rheumatol. 2014. PMID: 24128774
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial.
Smolen JS, Emery P, Ferraccioli GF, Samborski W, Berenbaum F, Davies OR, Koetse W, Purcaru O, Bennett B, Burkhardt H. Smolen JS, et al. Among authors: purcaru o. Ann Rheum Dis. 2015 May;74(5):843-50. doi: 10.1136/annrheumdis-2013-204632. Epub 2014 Jan 15. Ann Rheum Dis. 2015. PMID: 24431394 Free PMC article. Clinical Trial.
Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study.
Westhovens R, Ravelingien I, Vandevyvere K, Pansar I, Purcaru O, Kumke T, Gyselbrecht L. Westhovens R, et al. Among authors: purcaru o. Acta Clin Belg. 2019 Oct;74(5):342-350. doi: 10.1080/17843286.2018.1509923. Epub 2018 Aug 30. Acta Clin Belg. 2019. PMID: 30160189
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
Emery P, Bingham CO 3rd, Burmester GR, Bykerk VP, Furst DE, Mariette X, van der Heijde D, van Vollenhoven R, Arendt C, Mountian I, Purcaru O, Tatla D, VanLunen B, Weinblatt ME. Emery P, et al. Among authors: purcaru o. Ann Rheum Dis. 2017 Jan;76(1):96-104. doi: 10.1136/annrheumdis-2015-209057. Epub 2016 May 10. Ann Rheum Dis. 2017. PMID: 27165179 Free PMC article. Clinical Trial.
24 results